Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Iridex (IRIX) Preferred Shares Issued (2025)

Iridex has reported Preferred Shares Issued over the past 1 years, most recently at $6.0 million for Q1 2025.

For Q1 2025, Preferred Shares Issued changed N/A year-over-year to $6.0 million; the TTM value through Jan 2026 reached $6.0 million, changed N/A, while the annual FY2026 figure was $6.0 million, N/A changed from the prior year.
Preferred Shares Issued for Q1 2025 was $6.0 million at Iridex.
Over five years, Preferred Shares Issued peaked at $6.0 million in Q1 2025 and troughed at $6.0 million in Q1 2025.